[1]
“Therapeutic niche of ceftazidime-avibactam against gram-negative bacteria resistant to carbapenemics in Colombia: Nicho terapéutico de Ceftazidima-avibactam en Colombia”, Univ. Med., vol. 62, no. 2, May 2021, doi: 10.11144/Javeriana.umed62-2.nich.